In Kyrgyzstan, the prices for vital medicines will be regulated by the state rather than by private companies, said at a press conference Mariam Dzhankorozova, Head of the Division for Organization of Pharmaceutical Activities, the Department of Drug Provision and Medical Equipment, the Ministry of Health of the Kyrgyz Republic.
“We will start with 60 drugs. To assess the real cost of medicines, we will analyze their prices in other countries,” said Ms. Dzhankorozova.
Zhyldyz Zhumagulova, a specialist on drug policy of the Ministry of Health, said that at the moment the innovation would affect only the medications used in the treatment of hepatitis A and B, oncological diseases, and HIV infection.
So far, the experts find it difficult to predict when and how much the prices would fall. The experience of other CIS countries suggests that the preparations will take a couple of years, and the drop in prices will be very substantial. For example, in Azerbaijan, the prices for certain drugs have become dozens of times lower.